Right-heart valve deterioration traced to pacing type, revealing distinct tricuspid vulnerability with right-ventricular lead ...

BackgroundIt remains to be determined whether patients receiving cardiac resynchronization therapy (CRT) benefit from the addition of an implantable cardioverter‐defibrillator (ICD). Methods and ...

All patients who received a Medtronic market‐released ICD or cardiac resynchronization therapy defibrillator implant and were followed in the PSR registry by a US site were eligible for inclusion in ...

Commonly used devices include implantable cardioverter-defibrillators, devices for cardiac resynchronization therapy, and ventricular assist devices. Latest Research and Reviews.

Paradromics, a competitor to Neuralink, just implanted its device in a human brain for the first time. During a procedure on May 14 to help a patient with epilepsy, a team of surgeons, clinicians ...

The BIO-LIBRA study evaluated contemporary outcomes with an implantable cardioverter defibrillator vs. cardiac resynchronization therapy in patients with nonischemic cardiomyopathy, with an ...

Photograph of the in-situ electrochemical cell in place for the operando XAS measurements. Credit: Chemistry of Materials (2025). DOI: 10.1021/acs.chemmater.5c00387 ...